Artiva Biotherapeutics (ARTV) closed at $4.01 on November 13, 2026, up 1.3% from the previous close, on volume of 835,780 shares (30-day average 1,021,491).
Data as of November 13, 2026.
13-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 12, 2026. See the 10 largest for 30, 60 and 90 days
ACCESS Newswire (Fri, 13-Nov 10:30 AM ET)
PRNewswire (Thu, 12-Nov 10:15 AM ET)
Artiva halts AlloNK after durability fell short and two Grade 5 events were disclosed
Market Chameleon (Tue, 27-Oct 4:55 AM ET)
Artiva Biotherapeutics Announces Strategic Update and Discontinues Development of AlloNK
Globe Newswire (Tue, 27-Oct 7:30 AM ET)
Globe Newswire (Fri, 2-Oct 9:05 AM ET)
Globe Newswire (Thu, 1-Oct 7:30 AM ET)
Globe Newswire (Wed, 23-Sep 7:30 AM ET)
Artiva Biotherapeutics to Participate in the Stifel 2026 Virtual Immunology and Inflammation Forum
Globe Newswire (Thu, 17-Sep 8:00 AM ET)
Globe Newswire (Tue, 8-Sep 7:30 AM ET)
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in September
Globe Newswire (Wed, 2-Sep 8:30 AM ET)
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).
Artiva Biotherapeutics trades on the NASDAQ stock market under the symbol ARTV.
As of November 13, 2026, ARTV stock price climbed to $4.01 with 835,780 million shares trading.
ARTV has a beta of 4.15, meaning it tends to be more sensitive to market movements. ARTV has a correlation of 0.19 to the broad based SPY ETF.
ARTV has a market cap of $196.05 million. This is considered a Micro Cap stock.
The top ETF exchange traded funds that ARTV belongs to (by Net Assets): VTI, IWM, VXF, VTWO, VFMO.
ARTV has outperformed the market in the last year with a return of +18.3%, while the SPY ETF gained +13.4%. However, in the most recent history, ARTV shares have underperformed the stock market with its stock returning -64.5% in the last 3 month period and -4.3% for the last 2 week period, while SPY has returned -2.8% and -0.2%, respectively.
ARTV support price is $3.78 and resistance is $4.14 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ARTV shares will trade within this expected range on the day.
